Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Long-Term Investments (2021 - 2023)

Select Medical Holdings (SEM) has disclosed Long-Term Investments for 3 consecutive years, with $18.4 million as the latest value for Q2 2023.

  • For Q2 2023, Long-Term Investments changed N/A year-over-year to $18.4 million; the TTM value through Jun 2023 reached $18.4 million, changed N/A, while the annual FY2022 figure was $45.2 million, 150.35% up from the prior year.
  • Long-Term Investments hit $18.4 million in Q2 2023 for Select Medical Holdings, down from $27.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $45.2 million in Q4 2022 and bottomed at $18.1 million in Q4 2021.
  • Average Long-Term Investments over 3 years is $27.2 million, with a median of $22.7 million recorded in 2023.
  • On a YoY basis, Long-Term Investments climbed as much as 150.35% in 2022 and fell as far as 150.35% in 2022.
  • Select Medical Holdings' Long-Term Investments stood at $18.1 million in 2021, then surged by 150.35% to $45.2 million in 2022, then tumbled by 59.3% to $18.4 million in 2023.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $18.4 million, $27.0 million, and $45.2 million for Q2 2023, Q1 2023, and Q4 2022 respectively.